94.35 0.00 (0.00%)
After hours: 4:00PM EDT
Previous Close | 93.86 |
Open | 93.94 |
Bid | 94.33 x 800 |
Ask | 94.99 x 800 |
Day's Range | 93.86 - 94.42 |
52 Week Range | 48.02 - 95.43 |
Volume | 93,700 |
Avg. Volume | 305,873 |
Market Cap | 2.45B |
Beta (5Y Monthly) | 1.23 |
PE Ratio (TTM) | 6.30 |
EPS (TTM) | 14.98 |
Earnings Date | May 10, 2021 - May 14, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 94.00 |
Magellan Health (MGLN) partners Trapelo Health to offer an all-inclusive approach to value-based care in the innovative arena of precision oncology treatments.
Magellan Rx Management and Trapelo Health are collaborating to offer a precision oncology platform for next-generation care.
Amalgamated Employee Benefits Administrators, one of the nation's leading third party administrators (TPA) for unions, businesses, associations and self-insured plans, announced today that it has launched AEBRx (www.aebrx.com), a new Pharmacy Benefit Administration (PBA) service. This union affiliated, innovative, end-to-end PBA service will focus on helping plan sponsors effectively manage high-cost specialty drugs while providing excellent service and access to a national network of retail pharmacies with mail order capabilities. Amalgamated Employee Benefits Administrators has partnered with Magellan Rx Management, a full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN) as the engine for AEBRx.